Portfolio
Collective
Community
Team
Insights
Download our Term Sheet
Events
FAQ
Jobs
Privacy policy/GDPR
Whistleblower
Portfolio
January 8, 2024

Qvin's Q-Pad receives FDA clearance

In early January of 2024, Qvin made history; the FDA clearance of its Q-Pad and A1c Test marked the first FDA approval for menstrual blood health testing.

No items found.
Qvin's Q-Pad receives FDA clearance
No items found.
More about the author(s)
No items found.
More about the author(s)
No items found.

Related

September 11, 2026

Portfolio

Why we invested: Fluencify

Fluencify turns creator marketing from a coordination problem into an always-on growth channel.

August 27, 2026

Portfolio

Why we invested in Cota Robotics

Robots that run the store: physical AI for retail

May 19, 2026

Portfolio

Why we invested in Fload

The agentic OS for mobile apps.

Sign up to our newsletter.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Get access to exclusive insights from our community of world-class founders and operators, delivered quarterly to your inbox. We process your personal data in accordance with our privacy policy.

Follow us